<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03821428</url>
  </required_header>
  <id_info>
    <org_study_id>BB 166/18</org_study_id>
    <nct_id>NCT03821428</nct_id>
  </id_info>
  <brief_title>Acupuncture for Relief of Gag Reflex</brief_title>
  <acronym>AcuGag</acronym>
  <official_title>Acupuncture for Relief of Gag Reflex in Patients Undergoing Transesophageal Echocardiography - a Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to test whether stimulation of acupuncture points CV24 and P6 is&#xD;
      better than placebo acupuncture in treatment of gagging in patients undergoing elective&#xD;
      transesophageal echocardiography (TEE)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing elective transesophageal echocardiography (TEE) often report discomfort&#xD;
      because of active gagging reflex, which sometimes preclude the performance of TEE and&#xD;
      requires additional medication. According to existing literature, needling of acupoint CV24&#xD;
      effectively prevents gagging during dental procedures. We are going to use this phenomenon in&#xD;
      patients scheduled to TEE in order to reduce discomfort during insertion of TEE probe and&#xD;
      reduce the need for additional sedative medication. Within this investigation the patients&#xD;
      will be randomly assigned to receive either verum acupuncture of CV24 and P6 acupoints or&#xD;
      placebo procedure immediately before TEE examination. As outcome the incidence and intensity&#xD;
      of gagging, total dose of additional sedative medication and hemodynamic parameters will be&#xD;
      recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2019</start_date>
  <completion_date type="Anticipated">May 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of gagging during probe insertion</measure>
    <time_frame>10 minutes after TEE probe insertion</time_frame>
    <description>Incidence of gagging during TEE probe insertion: yes=1; no=2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gagging score</measure>
    <time_frame>10 minutes after TEE probe insertion</time_frame>
    <description>Gagging score on Verbal Rating Scale from 0 to 10, where 0=no discomfort from TEE probe; 10=maximal discomfort during TEE probe insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue medication</measure>
    <time_frame>10 minutes after TEE probe insertion</time_frame>
    <description>Use of midazolam as rescue medication, given as a summary dose of required midazolam from minimum 1 milligram to maximum 10 milligram</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gagging During Transesophageal Echocardiography</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Needling of acupoints P6 and CV24 with indwelling permanent needles, withdrawn after TEE procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Application of Placebo needles in the areas of P6 and CV24 acupoints</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Needling of P6 and CV24 points</description>
    <arm_group_label>Acupuncture</arm_group_label>
    <other_name>Verum acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Application of placebo acupuncture needles to the areas, where the acupoints are situated</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Placebo acupuncture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with an American Society of Anesthesiologists physical status of I to III&#xD;
             scheduled for elective ambulatory transesophageal echocardiography (TEE) without&#xD;
             sedation&#xD;
&#xD;
          2. TEE time does not exceed 30 minutes&#xD;
&#xD;
          3. Patients without previous opioid and psychotropic medication&#xD;
&#xD;
          4. Patients aged between 30 and 65 years, able to use visual analogue scale 100 mm&#xD;
&#xD;
          5. Patients who have given written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Current psychiatric disease&#xD;
&#xD;
          2. Local skin infection at the sites of acupuncture&#xD;
&#xD;
          3. Aged &lt; 30 or &gt; 65 years&#xD;
&#xD;
          4. TEE time more than 30 min&#xD;
&#xD;
          5. Patients who consumed opioid medication at least 6 months before surgery&#xD;
&#xD;
          6. Patients with the history of: i) psychiatric disease; ii) insulin-dependent diabetes&#xD;
             mellitus; iii) radio- or chemotherapy; iv) peripheral polyneuropathy.&#xD;
&#xD;
          7. Patients who are unable to understand the consent form or to use visual analogue scale&#xD;
             100 mm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taras Usichenko</last_name>
    <role>Study Chair</role>
    <affiliation>University Medicine of Greifswald</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taras Usichenko, MD, PhD</last_name>
    <phone>+49 3834865893</phone>
    <email>taras@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irina Müller-Kozarez, MD</last_name>
    <phone>+49 38348680699</phone>
    <email>irina.mueller-kozarez@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medicine of Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Müller-Kozarez, MD, PhD</last_name>
      <phone>+4938348680699</phone>
      <email>irina.mueller-kozarez@uni-greifswald.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gagging</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

